A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature
Joint Authors
Thapa, Bicky
Ali, Asad
Nair, Raunak
Vashisht, Rishik
Calabrese, Cassandra
Source
Issue
Vol. 2019, Issue 2019 (31 Dec. 2019), pp.1-9, 9 p.
Publisher
Hindawi Publishing Corporation
Publication Date
2019-11-03
Country of Publication
Egypt
No. of Pages
9
Main Subjects
Abstract EN
Immune-checkpoint inhibitors (ICIs) have revolutionized the treatment of cancer, yet therapy is often hampered by immune-related adverse events (irAEs) which range from mild to severe life-threatening events.
Musculoskeletal (MSK) irAEs leading to discontinuation of ICIs are uncommon but increasingly recognized.
We report a challenging case of severe immune-related seronegative inflammatory arthritis due to nivolumab in a patient with stage IV metastatic adenocarcinoma.
American Psychological Association (APA)
Thapa, Bicky& Ali, Asad& Nair, Raunak& Vashisht, Rishik& Calabrese, Cassandra. 2019. A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature. Case Reports in Rheumatology،Vol. 2019, no. 2019, pp.1-9.
https://search.emarefa.net/detail/BIM-1144184
Modern Language Association (MLA)
Thapa, Bicky…[et al.]. A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature. Case Reports in Rheumatology No. 2019 (2019), pp.1-9.
https://search.emarefa.net/detail/BIM-1144184
American Medical Association (AMA)
Thapa, Bicky& Ali, Asad& Nair, Raunak& Vashisht, Rishik& Calabrese, Cassandra. A Case of Severe Seronegative Inflammatory Arthritis due to Nivolumab and Review of the Literature. Case Reports in Rheumatology. 2019. Vol. 2019, no. 2019, pp.1-9.
https://search.emarefa.net/detail/BIM-1144184
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references
Record ID
BIM-1144184
